NASDAQ: POM
Pomdoctor Revenue

Pomdoctor revenue was $48.11M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, POM annual revenue was $46.9M, with 9.1% growth year-over-year.

POM past revenue growth

How has POM's revenue growth performed historically?

Company
9.14%
Industry
3.65%
Market
19.48%
POM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
POM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
POM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

POM revenue history

Current Revenue
$46.9M
Current Earnings
-$19.6M
Current Profit Margin
-41.9%

Be the first to know when POM announces revenue.

POM Revenue History By Year

POM Yearly RevenuePOM RevenuePOM ChangePOM Revenue Growth
2024-12-31$46.93M$3.93M+9.14%
2023-12-31$43.00MN/AN/A

1 of 1

Pomdoctor Revenue FAQ

What was POM's revenue last quarter?

Pomdoctor (NASDAQ: POM) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Pomdoctor's revenue was N/A.

What was Pomdoctor's revenue in 2024?

Pomdoctor's annual revenue for the twelve months ending Dec 31, 2024 was $46.93 million, a 9.14% increase year over year.

How much does Pomdoctor make in a day?

Based on Pomdoctor annual revenue for the past one years, POM makes an average of $128,563.68 per day.

What was Pomdoctor's annual revenue growth in the past year?

As of Q4 2025, Pomdoctor's revenue has grown 9.14% year over year. This is 5.48 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of 3.65%. Pomdoctor's revenue in the past year totaled $48.11 million.

How much does Pomdoctor make in a year?

Pomdoctor's revenue by year for the past one years is:
  • Pomdoctor's revenue for the twelve months ending Dec 31, 2024 was $46.93 million, a 9.14% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.